文献詳細
特集 泌尿器癌局所療法─局所を制する者は全身を制す
〈前立腺癌〉
文献概要
▶ポイント
・前立腺癌に対し多くの放射線治療が行われているが,局所再発を起こした場合に強く推奨される救済治療はない.
・造影MRIとテンプレート針生検で再発部位を詳細に同定し,その部分だけの治療ができれば内分泌治療などの全身治療は不要となる.
・局所治療で管理できれば小さな病巣だけの未治療前立腺癌に凍結治療が適応できるかもしれない.
・前立腺癌に対し多くの放射線治療が行われているが,局所再発を起こした場合に強く推奨される救済治療はない.
・造影MRIとテンプレート針生検で再発部位を詳細に同定し,その部分だけの治療ができれば内分泌治療などの全身治療は不要となる.
・局所治療で管理できれば小さな病巣だけの未治療前立腺癌に凍結治療が適応できるかもしれない.
参考文献
1) Wilt TJ, Brawer MK, Jones KM, et al : Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 367 : 203─213, 2012
2) Bill-Axelson A, Garmo H, Holmberg L, et al : Long-term distress after radical prostatectomy versus watchful waiting in prostate cancer : a longitudinal study from the Scandinavian Prostate Cancer Group-4 randomized clinical trial. Eur Urol 64 : 920─928, 2013
3) Ahmed HU : The index lesion and the origin of prostate cancer. N Engl J Med 361 : 1704─1706, 2009
4) Karavitakis M, Winkler M, Abel P, et al : Histological characteristics of the index lesion in whole-mount radical prostatectomy specimens : implications for focal therapy. Prostate Cancer Prostatic Dis 14 : 46─52, 2011
5) Turkbey B, Xu S, Kruecker J, et al : Documenting the location of prostate biopsies with image fusion. BJU Int 107 : 53─57, 2011
6) Stamey TA, Freiha FS, McNeal JE, et al : Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer 71 : 933─938, 1993
7) Sasaki H, Kido M, Miki K, et al : Salvage partial brachytherapy for prostate cancer recurrence after primary brachytherapy. Int Urol 21 : 572─577, 2014
8) Gage AA : History of cryosurgery. Semin Surg Oncol 14 : 99─109, 1998
9) Onik GM, Cohen JK, Reyes GD, et al : Transrectal ultrasound-guided percutaneous radical cryosurgical ablation of the prostate. Cancer 72 : 1291─1299, 1993
10) Ward JF and Jones JS : Focal cryotherapy for localized prostate cancer : a report from the national Cryo On-Line Database (COLD) Registry. BJU Int 109 : 1648─1654, 2012
11) Roach M 3rd, Hanks G, Thames H Jr, et al : Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer : recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 65 : 965─974, 2006
12) Satoh T, Matsumoto K, Fujita T, et al : Cancer core distribution in patients diagnosed by extended transperineal prostate biopsy. Urology 66 : 114─118, 2005
13) NCCN Guideline 2016 v4
14) 日本泌尿器科学会 (編) : 前立腺癌診療ガイドライン2016年版. メディカルレビュー社, 東京, 2016
15) Chade DC, Shariat SF, Cronin AM, et al : Salvage radical prostatectomy for radiation-recurrent prostate cancer : a multi-institutional collaboration. Eur Urol 60 : 205─210, 2011
16) Gotto GT, Yunis LH, Vora K, et al : Impact of prior prostate radiation on complications after radical prostatectomy. J Urol 184 : 136─142, 2010
17) Bates AS, Samavedi S, Kumar A, et al : Salvage robot assisted radical prostatectomy : A propensity matched study of perioperative, oncological and functional outcomes. Eur J Surg Oncol 41 : 1540─1546, 2015
18) Kaffenberger SD, Keegan KA, Bansal NK, et al : Salvage robotic assisted laparoscopic radical prostatectomy : a single institution, 5-year experience. J Urol 189 : 507─513, 2013
19) Zugor V, Labanaris AP, Porres D, et al : Robot-assisted radical prostatectomy for the treatment of radiation-resistant prostate cancer : surgical, oncological and short-term functional outcomes. Urol Int 92 : 20─26, 2014
20) Peters M, Hoekstra CJ, van der Voort van Zyp J, et al : Rectal dose constraints for salvage iodine-125 prostate brachytherapy. Brachytherapy 15 : 85─93, 2016
21) Peters, M, van der Voort van Zyp J, Hoekstra C, et al : Urethral and bladder dosimetry of total and focal salvage Iodine-125 prostate brachytherapy : Late toxicity and dose constraints. Radiother Oncol 117 : 262─269, 2015
22) Crook J : RTOG 0526 Protocol Information : A Prospective Phase II Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Adenocarcinoma Following External Beam Radiotherapy. https://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?study=0526 (Updated 2014)
23) Crook J, O'Callaghan CJ, Duncan G, et al : Intermittent androgen suppression for rising PSA level after radiotherapy. N Engl J Med 367 : 895─903, 2012
24) Keating NL, O'Malley AJ and Smith MR : Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J Clin Oncol 24 : 4448─4456, 2006
25) Ng CK, Moussa M, Downey DB, et al : Salvage cryoablation of the prostate : Follow up and analysis of predictive factors for outcome. J Urol 178 : 1253─1257, 2007
26) Pisters LL, Rewcastle JC, Donnelly BJ, et al : Salvage prostate cryoablation : Initial results from the cryo on-line data registry. J Urol 180 : 559─563, 2008
27) Spiess PE, Levy DA, Pisters LL, et al : Outcomes of salvage prostate cryotherapy stratified by pre-treatment PSA : Update from the COLD registry. World J Urol 31 : 1321─1325, 2013
28) Williams AK, Martinez CH, Lu C, et al : Disease-free survival following salvage cryotherapy for biopsy-proven radio-recurrent prostate cancer. Eur Urol 260 : 405─410, 2011
掲載誌情報